Lifting The Veil: Do Health Care Price Transparency Laws Actually Lower Costs? by Langendorf, Nora Michelle Irene
UNLV Theses, Dissertations, Professional Papers, and Capstones 
12-15-2019 
Lifting The Veil: Do Health Care Price Transparency Laws Actually 
Lower Costs? 
Nora Michelle Irene Langendorf 
Follow this and additional works at: https://digitalscholarship.unlv.edu/thesesdissertations 
 Part of the Public Policy Commons 
Repository Citation 
Langendorf, Nora Michelle Irene, "Lifting The Veil: Do Health Care Price Transparency Laws Actually 
Lower Costs?" (2019). UNLV Theses, Dissertations, Professional Papers, and Capstones. 3817. 
http://dx.doi.org/10.34917/18608696 
This Dissertation is protected by copyright and/or related rights. It has been brought to you by Digital 
Scholarship@UNLV with permission from the rights-holder(s). You are free to use this Dissertation in any way that 
is permitted by the copyright and related rights legislation that applies to your use. For other uses you need to 
obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons 
license in the record and/or on the work itself. 
 
This Dissertation has been accepted for inclusion in UNLV Theses, Dissertations, Professional Papers, and 












Nora M. I. Langendorf 
 
Bachelor of Arts – English 
University of Nevada, Las Vegas 
1994 
 
Master of Education – Educational Leadership 
University of Nevada, Las Vegas 
2004 
 
A dissertation submitted in partial fulfillment  
of the requirements for the 
 
Doctor of Philosophy – Public Affairs 
 
School of Public Policy and Leadership 
Greenspun College of Urban Affairs 
The Graduate College 
 



















Copyright 2020 by Nora M. I. Langendorf 















The Graduate College 
The University of Nevada, Las Vegas 
        
November 13, 2019
This dissertation prepared by  
Nora Langendorf 
entitled  
Lifting The Veil: Do Health Care Price Transparency Laws Actually Lower Costs? 
is approved in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy – Public Affairs 
School of Public Policy and Leadership 
 
                
Christopher Stream, Ph.D.       Kathryn Hausbeck Korgan, Ph.D. 
Examination Committee Chair      Graduate College Dean 
 
Patricia Cook-Craig, Ph.D. 
Examination Committee Member 
        
Jessica Word, Ph.D. 
Examination Committee Member 
 
Christopher Cochran, Ph.D. 







The purpose of this research is to determine whether or not health care transparency laws, 
in the form of price transparency, lower the rate of increase paid out in health care expenditures in 
those states that have enacted these laws compared to those states that have not.  By controlling 
for  factors such as poverty, age, chronic illnesses, and income that may play a part in lowering or 
raising health care costs, the primary explanatory variable – health care price transparency laws – 
can determine if there is a strong relationship with the dependent variable (the rate of increase on 
health care expenditures paid out in each state per person from 2000 to 2014) by using the Multiple 
Linear Regression of analysis.    
Implications of this research includes possible policy initiatives by those states that do not 
require healthcare data transparency.  For this research, policy outcome and effectiveness are far 
more important than policy creation.  One of the primary reasons for why the State of 
Massachusetts created policy in this domain was in order to mandate, “An Act Improving the 
Quality of Health Care and Reducing Costs through Increased Transparency, Efficiency and 
Innovation.” (ncsl, 2019). 
The value of this research is that the more we focus on how individual states manage costs, 
the more equipped state legislators dealing with the high cost of health care can attain knowledge 
about their options. Another benefit that flows solely from states that require costs be accessible 
to the general public will, itself, become a catalyst for lower costs. While this benefits the 
consumer, it also benefits those health care professionals who are tasked with cost oversight as 
they will also benefit from research that digs deeper into how transparency offers them another 
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Chapter 1: Introduction 
 
Stating the Problem 
   
 Over the years, health care costs have risen at an alarming rate.  As of 2017, health care 
costs us 3.5 trillion dollars and equaled up to 17.9% of our Gross Domestic Product (GDP) 
(Amadeo, 2019).  In 2009/2010, President Obama’s administration spent much of his political 
capital attempting to ‘lower the cost curve’ by mandating that insurance companies cover pre-
existing conditions, as well as keep costs down for the elderly as it was hoped that most of the 
cost-sharing would be shouldered by the young and the healthy. This policy did not play out as 
intended as Millennials opted to pay the tax penalty rather than pay hundreds of dollars a month 
in premiums, as well as high deductibles that priced them out of the market (Herman, 2016).  
One of the unintended consequences is that insurance companies could no longer afford to 
continue covering patients thus creating a void (Khazan, 2017) that reduced competition thereby 
increasing costs.  
 While policy makers at the federal level sought solutions by observing how other 
countries are successful at managing costs - such as Great Britain’s National Health System –
(The Economist, 2017), at the state level, legislatures and governors are following a different 
path. The primary impetus for seeking new ways to address issues that are normally handled by 
the federal government is the pension for gridlock, and as a result of separation of powers,  the 
increasing partisanship that has evolved due to a chasm created as each party shifts further from 
the center (Binder, 2014).   Since the 1970’s various states have required some level of health 
care data reporting.  Some states, such as North Carolina mandate only that “…state-wide 
processors create a portal” (NCSL, 2017) comparing the prices of the 35 most common surgical 
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procedures using data from hospitals and freestanding ambulatory surgical facilities.”  Other 
states, such as Arizona, require that a uniform ‘patient reporting system’ be in place where 
average charge per patient as well as the average costs physicians’ (NCSL, 2017).  While 
innovative, do these mandates actually achieve their goal of lowering healthcare costs?  What 
other factors might be involved in raising or lowering the rate of increase each state pays per 
capita for health care?  These questions form the crux of this research. 
Significance of the Research 
 The findings of this research will show whether Health Care Price Transparency laws 
actually lowers the rate of growth in health care spending in each state that has passed these 
mandates.  If so, should other states follow suit?  If not, why continue to create these mandates 
rather than looking to other solutions? 
Outline of the Study 
 Chapter 1 introduces historical background, at the federal level, on laws that have been 
passed to help lower costs in health care spending.  This culminates in the Patient Protection and 
Affordable Care Act passed in 2010.  This chapter also includes background information on 
Health Care Price Transparency laws passed by certain states, as well as the significance of this 
research.  This chapter concludes with an overview of chapters 2-6. 
Chapter 2: Lit Review 
 Chapter 2 will focus on defining possible drivers of increased health care costs, as well as 
attempts at the federal level to find solutions as found in the literature.  This chapter also covers 
what health care data is and how it is used by both government and consumers.  Dr.  G. Scott 
Gazelle (2010) notes that more research should be carried out in the area of health care 
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transparency on a comparative level, but there is no literature available regarding studies 
conducted on a Cost Effectiveness Analysis (CEA) on whether or not health care costs paid by 
the individual states are lower due to price transparency.  This dissertation seeks to try and fill 
that gap.   
Health care data transparency can take many forms.  Some states require that Universal 
Billing Files (UB04 Medicare claim forms) be submitted for auditing purposes, some of which 
has been codified to include DRG’s; as well as’ payer codes, in order to contain health care costs 
Some states require Inpatient/Outpatient facilities supply information that is oriented  towards 
giving consumers access to health care pricing information.  Details about upfront data such as 
how much a procedure will cost, as well as the average length of stay for inpatient procedures 
can be found on sites such as Nevada Compare Care which includes in its mission programs that 
increase awareness regarding hospitals and surgical centers for ambulatory patients 
(NevadaCompareCare.net) (ncsl.org, 2017). The literature review will also cover, in detail, the 
underlying reasons for including data for the independent variables such as average income by 
state, percentage of those living in poverty, percentage of the population 65 years or older, as 
well as political ideology and geographical regions.  Finally, chapter 2 goes focuses on how 
health care data differs depending on the level of complexity.  As noted by the National 
Conference of State Legislatures, part of the reason that states mandate health care data 
submissions are to track cost, which could be accomplished by UB04 billing files alone.  If this 
is the case, what is the purpose in creating public access for consumers?  Could part of the reason 
consumers demand access to cost information be due to the trend in high deductible insurance 
plans? Is part of the reason because states believed that if they empower consumers, this in turn 
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will also reduce costs? If so, what are the limitations with regards to how the information 
empowers the consumer?  
Chapter 3: Methodology 
 This research will focus on whether the policy goals of lowering health care costs within 
each participating state actually does what it is designed to do: use transparency as a means to 
lower costs.  Multiple Linear Regression Model, where the rate of increase in costs associated 
with health care is incurred by each state per capita is the dependent variable by which we 
measure the strength of the relationship between health care price transparency laws, as well as 
the following independent variables: years 2000-2014 to track the rate of growth (percentage) 
from year-to-year for each state, demographic information -average house hold 
income/percentage of population living in poverty, elderly population.  Controlling for factors 
such as obesity, hypertension, diabetes – all of which are covered in the healthy states index used 
as an independent variable is vital because these chronic conditions increase health care costs for 
all concerned.  Geographical consideration is also important as those who live in rural areas are 
greatly impacted by lack of medical resources within proximity to where they live. 
 Chapter 3 concludes by focusing on policy outcomes.  There are many examples where 
state initiatives, such as seatbelt laws, speed limits, and texting while driving have achieved their 
stated goals of saving lives.  Policy goals are important factors in policy creation, but if they are 
not measured, effectiveness is uncertain. 
Chapter 4: Results 
 The results of the Multiple Linear Regression Model will be detailed in this chapter in 
terms of inferential statistical analysis.  The p value of the Primary Independent Variable will 
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help determine if the null hypothesis that health care data transparency laws have no significant 
impact in predicting lower costs can be rejected or if the alternate hypothesis that these laws do 
positively impact health care costs must be accepted.  
Chapter 5: Conclusion 
This chapter will focus on what we can conclude if the research shows there is no 
significant correlation between the dependent and independent variables used to reject the 
alternate hypothesis?  Are there other ways to measure the stated goals of lowering health care 
costs?  Are there ways in which transparency can have a positive impact on health care? What 
can we learn if the opposite is true?  If health care data transparency laws result in lowering 
health care costs, should every state be forced to adopt some form of these laws?  If so, what 
would that look like?  
Chapter 6: Discussion of Limitations & Recommendations 
 This chapter discusses some limitations with the data such as the fact that the 
transparency requirements differ from state to state.  Some states only require internal 
submissions for auditing and oversight by designated state entities.  Other states, such as 
California, require more extensive transparency in areas including prescription drug prices.   
How do state entities tasked with the collection and distribution of the data go about increasing 
consumer awareness?  
 Recommendations for future research include limiting Information Asymmetry and 
Principle Agent Problem as these are major obstacles in reaching the primary goals of 
transparency – consumer use. 
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While all of these considerations are important, if transparency laws make a significant 
impact on how much each state pays to care for its citizen’s health, might it be worth it for the 
federal government to adopt a national, uniform model based on the best practices of those states 


























Chapter 2: Literature Review 
 
This chapter focuses on defining: 
 Transparency 
            Drivers of health care costs 
 What health care data is 
 How health care data is used by the state 
 How health care transparency data used by consumers 
  
 
Before exploring the specifics of health care data transparency laws, it is beneficial to 
look at why politicians at the state level decided to mandate transparency laws in the first place.  
Health care costs have been at the forefront of the national discussion since at least 2009 when 
the legislative machinations of reconciliation helped push through the Patient Protection and 
Affordable Care Act that was signed into law in 2010.  The passion with which different factions 
fought for their vision of health care reform bespoke of how divided we are as a nation when it 
comes to the topic of how to lower costs while increasing access to health care for those who 
have largely been ignored (Ornstein, 2015).  While legislatures at the federal level look at 
models used by other nations, state legislatures have chosen to focus on the primary source of 
health care costs at the point of access. 
Transparency 
The American College of Physicians defines health care transparency as, “…making 
available to the public, in a reliable, and understandable manner, information on the health care 
system’s quality, efficiency and consumer experience with care, which includes price and quality 
data, so as to influence the behavior of patients, providers, payers, and others to achieve better 
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outcomes (quality and cost of care)” (ACP, 2010).  In the ACP’s policy paper, they highlight 
different types transparency, including quality and physician performance.  They go on to 
explain the importance of price transparency not only to stake holders, patients, and employees, 
but also to those tasked with creating policy. 
Drivers of Health Care Costs 
The transition between focusing solely on covering costs to lowering costs is a relatively 
new concept that was emphasized by President Obama when he introduced portions of the 
Affordable Care Act. According to Statistica, in 1960, 5% of our G.D.P. was spent on health care 
costs.  By 2008, that number had more than tripled to 16%.  Some of the primary drivers of 
health care costs include chronic illnesses such as obesity, diabetes, and hypertension.  Treating 
the elderly and the poor also drives up costs because they are more likely to be diagnosed with 
chronic illnesses and spend more time in hospital/skilled nursing facilities.  In order to avoid 
collinearity, all of these factors can be found under the umbrella of the Healthy states index used 
as an independent variable in this research.  The reasons for why they drive up costs, and why 
they need to be controlled for are listed below: 
Elderly Population 
  There are many factors that have contributed to these increased costs, most notably 
expenditures related to treating the elderly. It has always cost more to treat the elderly as they are 
prone to chronic illnesses, spend more time in the hospital and take longer to recover.  In fact, 
according to the Anderson Model of Health Utilization (Evashwick, Rowe Diehr, Branch, 1984), 
the elderly sees their health care providers, on average, 6.1 times a year more than their younger 
counterparts.  There is also the issue of nursing care costs which are predominantly used by those 
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who are 65 and older.  Health and Human Services predicts that with a spike in elderly 
population, coupled with a longer life span will increase the costs paid out by 
Medicaid/Medicare (Grabowski, Stewart, et al, 2010). 
The generational shift from the Greatest generation to the Baby Boomers places and even 
greater burden on health care costs, as the expected 75 million members of this generation are 
expected to retire at approximately 3 million boomers a year for the next 30-years.  Included in 
this number are health care professionals which will clearly have an impact on health services as 
they retire (Barr, 2014).  
Poverty 
In 2018, the poverty line, for a family of four is $25,750 (Amadeo, 2019). 
The challenges for those who live at, or below, the poverty line are many. They face the 
possibility of being stuck in a cycle of sickness, which increases their risk of staying if poverty.  
This is known as the “Health-poverty trap”.  Many scholars are beginning to see that health is 
tied to income. Those living in poverty are diagnosed with chronic illnesses such as diabetes, and 
heart disease than those who are in a higher income bracket.  Even one’s life-expectancy is tied 
to income levels.  (Khullar, Chockshi, 2018).  
 Health disparities between the rich and the poor are not only seen in economic spheres.  
Access to health care for the poor is limited – which can hinder health promotion as a means to 
get, and stay, healthy.  While the Affordable Care Act has increased access to many that were 
previously uninsured, it has not fixed all of the problems.  According to the Harvard Gazette 
(Powell, 2016), minority patients, such as African Americans, are treated differently even if they 
have the same insurance coverage as those who are not considered a minority patient.  Powell 
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states that different protocols are followed for treating African American patients suffering a 
heart attack.  This type of disparity can greatly influence the outcome as to whether the treatment 
was successful or not.  There are other factors outside of health care’s reach that can perpetuate 
the cycle of poverty such as fewer resources to education, quality food, and employment 
opportunities. These deficiencies, coupled with a lack of access to quality medical care, higher 
rates of chronic illnesses, create the health-poverty trap, and treating those who live at, or below, 
the poverty line can increase health care costs. 
Obesity 
 According to the Centers for Disease Control, obesity is at epidemic proportions 
(Campoy, 2019).   In the same article, Dr. Campoy writes, “Obesity has taken a toll on health 
care costs across the country—estimated between $147 billion and $210 billion in direct and 
indirect health care costs, as of 2010. “.   While the amount of calories we consume on a daily 
basis has something to do with how much weight we gain, the factors that contribute to obesity 
are also due to genetics and how fast or slow our bodies metabolize the calories (Harvard Health 
Publishing, 2019).  Those diagnosed with obesity are at an increased risk of having type II 
diabetes, heart disease, kidney disease, fatty liver, and other serious illnesses (NIDDK, 2015).  In 
order to lower health care costs, it is crucial that we, as a country, emphasize the benefits of 
exercise, healthy eating, and other healthy life-style choices. 
Diabetes 
 There are two types of Diabetes, Type I, and Type II.  Type I diabetes is normally 
associated with childhood and are primarily caused by variances in our genetic makeup (NIH, 
2019).    Type II Diabetes is far more prevalent among adults, and while genetics may play a part 
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in contracting this disease, environmental factors, such as obesity and level of physical activity 
also contributes to increasing the odds of having this disease.  The American Diabetes 
Association states that race, age, gender, and family history may determine who has diabetes.  
These are factors for which we have no control (ADA, 2019).  In The Cost of Diabetes, the ADA 
notes that there has been a 26% increase in health care costs over a five year span ranging from 
2012 to 2017.  Most of the costs are directly related to covering medical expenses such as 
supplies (testing meters, strips, needles, insulin, or oral medication), hospitalization for 
complications associated with diabetes, and indirect costs such as loss of productivity.  
Demographic statistics include: 
 Total per-capita health expenditures are higher among men than women ($10,060 vs. 
$9,110). 
 Total per-capita health care expenditures are lower among Hispanics ($8,050) and higher 
among non-Hispanic blacks ($10,470) and among non-Hispanic whites ($9,800). 
 Compared to non-Hispanic whites, per capita hospital inpatient costs are 23% higher among 
non-Hispanic blacks and 29% lower among Hispanics. Non-Hispanic blacks also have 65% 




 Where we live matters in terms of access, or lack thereof, to health care facilities.  One of 
the main reasons for the lack of health care access in rural areas is the distance it takes in order to 
see primary care physicians or obtain emergency care.  The Association of American Medical 
Colleges states that, “If you want to go to an OB/GYN, depending on where you live in the 
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country, you may have to go 200 miles” (Warshaw, 2017).   The Center for Disease Control 
(CDC) states that conditions such as heart disease, cancer, opioid overdoses, and strokes are 
higher in rural areas. Tobacco use amongst rural teens and adults is higher than those who live in 
urban areas, which may account for higher rates of cancer diagnosis in rural areas (Warshaw, 
2017).   
 Distance is not the only obstacle to being able to receive quality care for rural residents.  
There is also a shortage of providers – both primary and specialty care.  There are fewer mental 
health professionals in areas where they are needed most as those living in rural areas tend to 
participate in riskier behavior such as opioid use (Georgetown University, 2003).  
 Health insurance coverage plays a role in creating successful outcomes in terms of health 
promotion and early treatment. Medical testing for heart disease, cancer, diabetes, and other 
chronic illnesses, as well as helping patients become literate in health care issues they face, is 
key to early diagnosis and treatment which can lower costs. Unfortunately, those living in rural 
areas are less likely to be able to obtain health insurance than those living in an urban setting.  
One reason is that more states with rural populations opted out of the Medicaid expansion 
programs under the Affordable Care Act (Hoadly, Alker, Holmes, 2018).   
 All these factors (demographic, geographical, and chronic diseases have been shown 
throughout this chapter to impact health care costs.  For many years, the federal government has 
sought to help alleviate suffering from sickness and disease for those who are not able to acquire 
health care access on their own.  From Medicare and Medicaid to the Children’s Health 
Insurance Program (CHIP), they have been, by and large, successful.  The Affordable Care Act 
sets itself apart because it not only concentrated on creating more access for the uninsured, but it 
also focused on trying to lower health care costs by emphasizing the fact that when someone is 
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able to see a doctor regularly, illnesses and diseases are caught earlier and can be treated less 
expensively than if the same patient waited until having to go to the Emergency Room because 
the illness spiraled out of control. 
Indirect Costs 
Until now, the focus has been on direct costs and how they might be lowered, but there 
are indirect costs as well.  According to the American Medical Student Association, 86% of med 
students will carry student loan debts after graduation with an average total of $173,000.00 
(Kessler, 2018).  It makes sense that when bartering for salaries as a health care professional, the 
costs linked with obtaining their medical degree would be folded into the salary range.  One way 
that the federal government has sought to offset these costs while also increasing access to 
under-served areas is through programs that reward physicians – especially those who choose to 
become Primary Care Physicians – who choose to commit a portion of their career in these 
defined areas (Mareck, 2011). 
Malpractice insurance premiums also add to indirect costs, and depending on the state, 
can wildly vary driving some physicians to limit their practice to areas where premiums are 
lower.  For example, the high cost of malpractice insurance for OB/GYN doctors in the State of 
Nevada in the early 2000’s drove many of these specialists out our state.  According to Review 
Journal writer, “OB/GYN physicians were forced to leave Las Vegas due to skyrocketing 
malpractice insurance premiums, and patients could not find doctors to deliver their babies in 
Las Vegas” (Joecks, 2009).  Like student debt, these costs are passed onto the consumer via 
higher contract salaries, but the cost is not limited to the financial but also to limiting supply 
while demand remains unchanged.  One case study that reversed this trend focuses on tort 
reforms passed in the State of Texas in 2003 where the number of physicians increased faster 
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than the growth of population, including underserved areas of the state (Institute For Legal 
Reform). While many states have passed laws limiting (or capping) the amount of money juries 
can award for pain and suffering, according a the Government Accountability Office (GAO) the 
federal government has not been able to reach a consensus on what is a just compensation for 
medical malpractice (Finnegan, 2017).  
While the federal government tends to focus on a ‘one-size-fits-all’ solution such as 
mandating Minimum Essential Coverage plans sold on state exchanges (HealthCare.gov), some 
states have decided to tackle the high costs of health care from a different perspective. One of the 
ways some of the states have chosen takes the form of health care data transparency laws.  
Health Care Data Transparency Laws  
 There is a distinction to be made between the types of health care data that exist.  There is 
clinical data that is collected as part of patient care where information is stored on Electronic 
Medical Records (EMR) or Electronic Health Records (EHR).  Data that is stored in these types 
of data bases include patient demographics, known health risks, such as allergies, as well as any 
prescription drugs the patient may be taking. (Health Sciences Library, UW).  One of the primary 
reasons to collect clinical health care data is to provide continuity of care from Primary Care 
Physicians, to specialists, to Emergency Rooms where access to information such as knowing 
whether or not a person is diabetic or has a heart condition is critical to saving a life 
(USHealthonline).  
While the use of these systems is important, they focus more on patient health and do 
little to save money on health care other than at the point of access as it takes less manpower to 
manage than hard-copies due to its efficiency.  Dr. Danny McCormick argues that the ease in 
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which a physician can view prior test results and order new ones contributes to the overall cost of 
health care (NYT, 2012).  While interesting on its own merits, the primary focus for this research 
moves farther away from patient centered data and closer to billing data where information about 
costs for certain types of procedures, types of payment, and discharge data are formatted to make 
it easier to audit.  This type of data is foundational for the second type of health care 
transparency laws created to empower consumers in making educated decisions regarding their 
own health care. This is becoming increasingly important as the trend in health care coverage 
finds insurance companies offering plans with high premiums and high deductibles.  According 
to Drew Altman, with the Kaiser Family Foundation, the middle class is being especially hit hard 
with the reality that their health care costs are going higher (Levey, 2019). Unlike the upper 
classes who can afford to put money away in the form of tax-deferred Health Savings Accounts, 
or the lower class which qualifies for Medicaid, the middle class is feeling the pinch of being 
between a rock and a hard place.  Accordingly, this socio-economic group may benefit the most 
from HCPTL’s. An argument can be made that this segment of our society has a greater need to 
access health care price information because when faced with high deductibles and premiums, 
price shopping can make the difference between choosing, or foregoing, a procedure.  The 
Robert Wood Johnson Foundation believes that price transparency not only educates consumers, 
but actually lowers costs (RWJF, 2016). 
For the purpose of this Literature Review, most of the heath care data information 
included in this dissertation comes from The Center for Health Information Analysis. (see table 1 
below).  Like many states that have enacted transparency laws, Nevada collects billing records 
from every licensed hospital and Ambulatory Surgery Center for two reasons: 1. To ensure 





Table 1. UB04 codebook 








Provider (facility) Name 1 
  
25 
Patient Control Number 199 
  
20 










Statement Covers Period (From) 261 
  
10 
Statement Covers Period (Through) 271 
  
10 
Reserved FL07A 281 
  
7 
Patient Social Security Number 288 
    
9 
Patient First Name 297 
    
20 
Patient Middle Initial 317 
    
1 
Patient Last Name 318 
    
30 
Patient Suffix 348 
    
5 
Patient Street Address 353 
    
40 
Patient City 393 
  
30 
Patient State 423 
  
2 
Patient Zip 425 
  
9 





Patient Birth Date 436 
  
10 
Patient Gender 446 
  
1 
Patient Marital Status 447 
  
1 
Patient Race 448 
  
1 
Admission (Visit)/Start of Care Date 449 
  
10 











Discharge Hour 463 
  
2 
Discharge Status 465     2 




The billing file submitted by an ASC is similar to the format found in the Ambulatory 
Surgery Center UB04 Codebook shown above.  Although cost containment files include a lot of 
information, the key factors are Diagnosis Related Codes (DRG’s) Primary Payer Codes, Total 
Charges, Discharge Status Codes, and personal patient information such as name, SSN, and 
addresses.  Understanding why these key data points are collected is important if the focus is on 
using health care data to lower costs.  The reason these files are so important is for departments 
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such as the Division of Health Care, Finance, and Policy to be able to track charges and follow-
up with hospital administrators when they see any red flags. 
 Prior to 1983, under Medicare, hospitals were reimbursed under a system known as 
“Retrospective Cost-based reimbursement” throughout the year.  At the end of the year, hospitals 
would send the federal government a summation of the actual costs whose total would be much 
higher than the initial estimated cost.  In order to try and contain the costs associated with 
Medicare spending, Congress created the ‘Prospective Payment System (PPS) in 1982.  These 
types of cost containment initiatives took many iterations prior to the creation of Diagnosis 
Related Codes upon which the Federal Government has been utilizing, albeit after several 
revisions, ever since (OEI, 2001).  The current version of DRG’s International Classification of 
Diseases (ICD-10) cover procedures from Coronary Bypass to hernia operations (Foley, 2015).  
The main difference between ICD-9 codes and ICD-10 codes is that they offer more specificity 
and detail and are easier to group and measure outcomes (CMS.gov, 2017). 
 In 2015, the State of Nevada required that all hospitals and ambulatory surgical centers 
(ASC’s) include personal information about the patient such as their name, address, and social 
security numbers. (see exhibit A).  This data is vital to follow patient care across different digital 
platforms to track patient care, as well as re-admits for the same conditions that were treated by 
first admissions.   
 Primary Payer Codes are used to break down the various forms of payments.  These 
codes are required because the auditor wants to see the breakout of assigned codes in order to 
determine whether or not a certain code might be overused, such as code 19 (Miscellaneous) as 
this might issue a red flag where the facility is contacted to see if they can move some of the 
charges to a more specific Primary Payer Code. These payer codes also include several insurance 
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types such as Blue Cross, Health Plan of Nevada, Medicare/Medicaid, as well as, negotiated 
discounts, and cash payments.  The example cross walk (table 2 below). gives an example of the 
Primary Payer Code Crosswalk.  For the State of Nevada, hospitals and Ambulatory Surgery 
Centers will input their Primary Payer Codes in position 4065 of a text billing file.  Most 
correspond to insurance such as Nevada Medicaid (16) Medicare HMO (27) Self-Pay (18), or 
Miscellaneous (19.) 
  
Table 2. Primary payer code crosswalk 
 . Primary Payer Code Crosswalk   
PAYER 
CODES     
  
Payer codes are typically reported 
 based on the best information  
known at time of final billing (several 
days after discharge) 
  
      
Payer Code Definition Comments 
10 Medicare   
11 Black Lung   
12 Charity 
Cases in which the Hospital 
agreed to accept no or partial 
payment as the case met the 
Hospital's Medical Financial 
Hardship Policy 
13 Hill Burton Free Care (HBFC)   
14 CHAMPUS / CHAMPVA   
15 No Longer in Use   
16 Nevada Medicaid   
17 Other Medicaid People from out of the area (not NV) 
18 Self Pay 
Cases in which the patient has 
no insurance coverage of any 
kind. This should include 




19 Miscellaneous Does not fit any other category 
20 Commercial Insurer 
Patients that have insurance 
coverage through a carrier 
that does not have a contract 
with the Hospital allowing for 
payment at other than billed 
charges and should include 
cases in which the only 
coverage is Motor Vehicle 
Insurance (BC/BS without a 
contract goes here) 
22 Health Maintenance Organization 
Patients that have insurance 
coverage through a carrier 
that does have a contract with 
the Hospital allowing 
for  payment at other than 
billed charges and the 
product/benefit is an 
HMO  (BC/BS HMO goes 
here) 
23 County Indigent Referral 
Patient has already been 
approved for County 
Coverage 
24 All Worker's Compensation Cases   
25 No Longer in Use In the past, 25-26 were used as Blue Cross/Blue Shield 
26 No Longer in Use 
These will no longer be 
separated into their own 
categories. 
27 Medicare HMO   
28 Nevada Medicaid HMO 
Amerigroup & Sierra now do 
part of Nevada Medicaid 
HMO  BC/BS will now be 







What this translates to in a Standard Report looks something like this (see figure 1 below) This is 
where the information collected in the billing files becomes accessible to consumers who might 




Fig. 1. Standard report for hospital inpatient
 




Figure 1. shows that for Banner Churchill, Boulder City Hospital, and Carson Tahoe 
Hospital, Medicare pays the bulk of the cases. While this is just a small snippet of the data found 
on Nevada Compare Care, it does provide a window into how cases, length of stay (Days), 
charges and Percentage of CaseMix which Penttengill and Vertrees defines as an, “index is 
evaluated by estimating a hospital average cost function.” (1982).  A point of interest is that the 
Payer Code crosswalk skips from 20 to 22 on table 2 but is listed as a code for negotiated 
discounts (21) in table 3.  Negotiated discounts are rates that a hospital accepts, and an insurance 
company will pay.  Normally, the insurance companies that have a larger pool of insured 
potential patients obtains lower rates as the hospital considers a higher percentage of patients as 
good for business.  While this may benefit the insured, those that are uninsured pay much more 
for the same care.  Negotiated discounts serve to hide the true cost of healthcare, at least for the 
insured (Barrette, Brennan, 2017). 
Chargemaster 
A Chargemaster is list of charges for procedures and services that is hospital specific – 
which means that one hospital (say Summerlin Hospital) can charge a much higher, or lower, fee 
for a hip-replacement surgery than St. Rose De Lima in Henderson (Munro, 2013).  While 
transparency is a good thing, many were shocked to find out that hospitals were charging 
outrageous prices for rudimentary care such as routine bloodwork that hospitals charge Medicare 
much less (Brill, 2013).   
Because there is no uniform Chargemaster, figuring out what a procedure should cost is 
nearly impossible.  Some states have attempted to change all of that.  Currently, California is the 
only state that explicitly requires Chargemaster transparency.  Most of the states include a 
requirement where hospitals are required to post costs for procedures in some form for the 
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patients and their physicians, in the hope that making healthcare costs transparent will empower 
the consumer to make educated decisions. (NCSL, 2018).   The downside to Charge Master data 
(see figure. 2) are two-fold: 1.  The format and language of how the information is categorized is 
confusing to the average consumer not versed in ICD-9/CPT codes and/or trauma levels.  2. For 
information contained is of little use to patients admitted under emergent care either because they 
are unconscious, mentally altered, or in shock and are in no condition to make educated 
decisions about the costs of treatment they are about to receive. Finally, the price information 
listed on Charge Masters are often misleading because the price quoted may not necessarily 
show up on the patient’s final bill (HNN, 2019).  Because Charge Masters are required to be 
published in every state as part of the Affordable Care Act, it is not included as part of the 
dichotomous primary independent variable – mainly since it includes pricing on emergent and 
non-emergent care.  As noted earlier, emergent care does not afford the patient the ability to 
compare pricing.  Price transparency, through public access to portals where comparisons can be 
made such as NevadaCompareCare offer a more realistic option for consumers who wish to 
obtain up-front pricing on lab/imaging/procedural costs.  While Chargemasters include prices on 
procedures and tests, they don’t tend to show average costs for hospitalization length of stays or 
quality outcomes which are important factors in the decision-making process. 
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Fig. 2. Antelope Valley Hospital chargemaster 
 
 
Consumer-driven healthcare data 
In the Journal of the American Medical Association (JAMA), President Obama published 
an article outlaying how the Affordable Care Act provided access to coverage to millions of 
Americans who were previously uninsured (NCBI, 2016).  Prior to the Affordable Care Act, the 
majority of the population in this country received insurance coverage as a benefit of 
employment.   According to (Enthovan, 1999), one of the reasons that managed care 
(HMO/PPO) groups do not lower health care costs is because it is easy to hide the true cost of 
health care because cost sharing lowers the amount of money paid by the patient in the form of 
lower co-pays and deductibles.  The days of paying Fees for Service (FFS) began to decrease as 
managed care enrollment increased.  The "elasticity of demand” Enthovan argues, triggers higher 
healthcare costs because consumers don’t see the entire costs, just the co-pays, and/or premiums.  
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When consumers aren’t privy to the entire costs associated with their care, they tend to over-use 
the resource, which drives up costs.  
 One of the ways that states have developed to open the eyes of consumers to these 
charges is through the concept of health care transparency via online access to patient portals, or 
through written estimates of costs upon patient request (LaPointe, 2018).  Various states have 
incorporated these types of portals where consumers can log on to find out information such as 
the cost of a hip replacement at one hospital in comparison to another.  In Nevada, consumers 
can also research the quality of care by facility (see fig.3 below): 
 











 As shown in figure 3, a consumer in Nevada can access information about procedures by 
hospital, type of surgery (in this case Coronary Bypass - CABG) as well as by physician.      
Through the collection of health data and the compilation of common procedures, public 
databases, normally in the form of an accessible website, consumers can navigate these websites 
to find information on surgeons, hospitals, average length of stays and average charges.  
Unfortunately, according to the Harvard Business Review (Kullgren, 2015) only 10% of the 
population actually look up health care price comparisons.  Kullgren notes that two of the major 
hindrances that leave consumers confused is the lack of uniformity in pricing and the fact that 
billed charges are used as the source of the price comparisons and leave out charges for quality 
of care given by different inpatient/outpatient facilities. Another obstacle that may present itself 
to consumers is that the information available is not always consumer friendly.  For example, 
most consumers, who are not health care professionals, do not understand the various 
diagnosis/CPT codes.  As a result, navigating through these portals can leave consumers 
frustrated. As of this writing, only one state, Kentucky, is required to create a website that is user 
friendly (NCSL, 2019). As more adults move from traditional plans to high deductible plans 
(Inserro, 2018), having the ability to compare costs of procedures becomes more important. As 
useful as this information may be, it does not take into account the fact that if a patient’s cardiac 
surgeon does not have privileges at a particular hospital/ASC, then the patient is left with a 
choice of either obtaining a second-opinion from another specialist that does have privileges or 
sticking with the first specialist thereby restricting their choice of facilities in which to have the 
procedure performed.  
 One of the most contentious battles that took place in recent years in the area of 
transparency occurred when it was revealed that the Nevada Legislature began to require that 
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hospitals reveal Hospital Acquired Conditions (HAC’s). The incidents of these conditions range 
from foreign objects left in the body to contract deadly strains of bacterial infections.  Not 
surprisingly, for many years, hospital lobbyists fought against this mandate. The importance of 
disclosing this information is two-fold: 1. It helps consumers make informed decisions as to 
which hospital has the lowest, and highest, number of recorded HAC’s,  According to 
Assemblywoman Sheila Leslie, “The more transparency there is the better, (so) consumers can 
choose their health care facilities,” and 2. Its negative re-enforcement tends to incentivize 
hospital administrators to take action in reducing the number of HAC’s in the form of lowering 
Medicare reimbursements for hospitals that do not take the need for reductions seriously (Allen, 
Richards, 2010).  Hospital Acquired Conditions also increase health care costs as the average 
length of stay, in many cases, are extended.  This is also true as treating illnesses/injuries caused 
by these incidents on top of the treatment for the original admission add to the cost of treating 
patients. 
 Since 1977, certain state legislatures have required some form of health care data 
transparency.  The stated purpose of initiating these mandates are, “…health care price 
transparency or disclosure has emerged as a hot topic in state legislatures, as a strategy for 
containing health costs. States, the federal government, and the private sector have enacted legal 
requirements and initiated programs that aim to shed light on the costs of health care services” 
(NCSL, 2017.) Of the 28 states listed by the National Conference of State Legislatures (NCSL, 
2017) are as follows: Delaware, Indiana, Kentucky, Maine, Missouri, Nebraska, Nevada*, and 
Washington only require a single piece of legislation. These can range from requiring the 
notification by hospitals the costs associated with hospital care (Washington) to requiring that all 
hospitals and providers “provide charge data to the Department of Health and Senior Services”.   
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The state that requires the most complex set of data is California.  The most common form of 
data required by the states listed in this report point to information provided for the consumer 
lists the expected charges for procedures.  The states (see Table 1) that disclose data for public 
access include: Arizona, Arkansas, California, Colorado, Delaware, Florida, Illinois, Kentucky, 
Massachusetts, Minnesota, New Hampshire, Ohio, South Dakota, Texas, Virginia, Vermont, and 
Washington. 
 States in bold font (see table 3 below) have either enacted laws requiring that health care prices 
are made available to the public from consumer databases or written estimates.  *Nevada does 
not require the creation of public data but has none-the-less created this portal for consumer 
access via NevadaCompareCare. 
 
 
                      Table 3.  States that have enacted health care transparency laws. 






Arizona 1993  Nevada 1987 
Arkansas 1994  New Hampshire 2003 
California 2003  N. Carolina 1995 
Colorado 2003  Ohio 1992 
Delaware 1989  Oregon 1977 
Florida 1982  Pennsylvania 1986 
Illinois 1984  Rhode Island 1998 
Indiana 1993  S. Dakota 1994 
Kentucky 1994  Texas 2007 
Maine 1995  Utah 1990 
Massachusetts 2012  Virginia 1996 
Minnesota 2004  Vermont 1991 
Missouri 1992  Washington 1993 




This chapter covered health care data/price transparency laws that benefits both 
legislatures and consumers alike to help lower health care costs by making data accessible to 
both. Disclosure of this data helps state legislatures track costs through the submission ofUB04 
billing claims.  The compilation of several price points helps the consumer make informed 
decisions while increasing their knowledge of the true costs of treatment. As noted earlier in this 
chapter, by increasing transparency, the hope is that this type of accountability will force 
hospitals to step up by policing themselves to lower Hospital Acquired Conditions (HAC’s), as 
well as providing the costs linked to procedures prior to consenting to undergo treatment.  
Transparency at the state level is important so that those tasked with tracking costs can audit 
hospital and ASC records to ensure that these facilities are compliant with state mandates.  
Another positive aspect of transparency in the health care is the promotion of competition which 
tends to lower prices as hospitals and caregivers seek a greater piece of the market pie 
(Gustafsson, Bishop 2019). 
 The next chapter will focus on whether health care price transparency is a vehicle for the 
purpose of lowering health care costs.  Health care policy is vast, and like most initiatives, 
success comes through trial and error.  From the creation of health insurance to Medicare and 
HMO’s, the landscape is replete with failure as governors and state legislatures attempt to come 







Chapter 3: Methods 
 
Variables 
The central question this research seeks to answer is whether health care price 
transparency laws may or may not be a factor in lowering rate of growth in health care costs.  In 
order to see if these laws achieve their objective, the methodology that best fits this purpose is by 
using the Multiple Linear Regression. According to Stat.Yale.edu, “…linear regression attempts 
to model the relationship between two or more explanatory variables and a response variable by 
fitting a linear equation to observed data. Every value of the independent variable x is associated 
with a value of the dependent variable y.” In other words, the main function for the Linear 
Regression model is to find possible correlations between explanatory variables (independent 
variables) on the outcome variable (dependent variable 
  By assigning the  rate of growth from 2000-2014 that each state has paid in per capita 
spending as the Dependent Variable (DV) and whether or not a state requires Healthcare Price 
Transparency Laws (0=no, 1=yes) as one of the Independent Variables (IV) we can control for 
other factors such as age and poverty by including the Healthy States Rankings that may also 
account for an increase/decrease in costs by measuring whether or not an increase in poverty or 
elderly populations, as well as geographical and economic factors that may have an impact on 
raising, or lowering the rate of increase in healthcare costs at the state level.   
In order to calculate the rate of increase in health care costs using data from the Kaiser 
Family Foundation, we subtract the previous year’s dollar amount from the current year’s 
dollar amount and then divide by the current year’s health care expenditures (current year-
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previous year/current year).   According to the Kaiser Family Foundation web page, they 
define health care expenditures for each state as,  
“Health spending per capita includes spending for all 
privately and publicly funded personal health care services and 
products (hospital care, physician services, nursing home care, 
prescription drugs, etc.) by state of residence (aggregate 
spending divided by population). Hospital spending is included 
and reflects the total net revenue (gross charges less contractual 
adjustments, bad debts, and charity care). Costs such as 
insurance program administration, research, and construction 
expenses are not included in this total.” 
 
 According to a study conducted by the Harvard Chan School (Blumberg, 
2018), the reason health care costs in the United States are much higher than 
other industrialized countries has nothing to do with utilization as much as it 
does with inflated prices.  The primary culprits are prescription drug costs and 
physician salaries.   Blumberg notes that drug prices are higher than prices paid 
in other countries and physicians, on average, get paid over $100k more than 
their counterparts in other countries. For this reason, the data obtained from the 
Kaiser Family Foundation was chosen because it not only includes costs 
associated with hospitalization, but also those incurred from prescription drug 
prices and physicians that reflect a more detailed description of health care costs 
than data that focuses solely on hospital charges.   
 The other factor that weighed favorably in the Kaiser Family 
Foundation’s favor is that there is a lack of a centralized database that exists 
solely for the purpose of calculating costs due to hospitalization.  The Health 
Care Utilization Project does collect data on hospital costs at the national level, 
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but it does not break out the costs spent in each state (Pfuntner, Weir, Steiner, 
2013). 
Healthy State Rankings/Values 
In previous models, several independent variables were used as control variables if the 
regression model showed a statistically significant relationship between the primary dependent 
variable and the response variable.  The variables included data on poverty rates, percentage of 
the elderly population residing in each state, as well as geographic information defined as rural 
vs. urban population.  The results of the regression analysis showed that the model was riddled 
with collinearity errors.  For this reason, The Healthy States rankings were substituted  as they 
are comprehensive and cover, but are not limited to, the list of categories found in Table 4  The 
rankings cover everything from lifestyle choices such as smoking, binge drinking, to the 
economic, age, gender, and chronic illnesses, as well as uninsured and geographic (rural, urban, 















Table 4.  Partial metadata for healthy state rankings 
Edition 
Report 
Type Measure Name State Name Rank 
2014 
2014 
Annual Diabetes - $25-$49,999 Alabama 50 
2014 
2014 






Diabetes - American Indian/Alaskan 
Native Alabama  
2014 
2014 
Annual Diabetes – Female Utah 3 
2014 
2014 
Annual Diabetes – Rural Connecticut  
2014 
2014 
Annual Diabetes – Suburban Maine 25 
2014 
2014 
Annual Heart Disease United States  
2014 
2014 
Annual Obesity United States  
2014 
2014 
Annual Personal Income, Per Capita  Alabama 44 
2014 
2014 
Annual Preventable Hospitalizations Alabama 43 
2014 
2014 
Annual Uninsured United States   
 
 
The Rankings calculations are a “composite index of all core measures included in the 
report” Core measures are defined as Behaviors, Community and Environment, Public and 
Health Policies, Clinical Care and Outcomes.  Once the data is gathered, it is then normalized by 
state for each measure by using U.S. value by calculating the z score. The z score for each 
measure is found by dividing the state value minus the national value from the standard deviation 
of all state values. (AHR, 2019) 
 Once all of the outliers have been removed, the z scores for each measure are multiplied 
















  The multiple linear regression will be run with the IV’s below: 
Years coded 2000 to 2014  
Health Care Price Transparency Laws – Primary IV dichotomous variable (0/1) 
Healthy States values - Control variable 
Results driven research 
 The journal, Policy and Society (Head, 2017) notes that research that focuses on 
findings help policy makers develop improve on decision making skills to improve on 
existing policies and in shaping new policies.  Health care costs impact everyone, directly, 
or indirectly.  So, achieving the stated goals of lowering them takes precedent over how 
policy is created.   There are many examples of policy outcomes that have been successful 
such as stricter DUI laws lowering blood alcohol levels and increasing check points 
potentially save hundreds of lives a year (LaMotte, 2018).  Common sense mandates such 
as the prohibition on texting while driving and seatbelt laws do the same.  According to the 
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National Highway Traffic Safety Administration (NHTSA), seatbelt laws have saved over 
14,000 lives in 2017 (NHTSA, 2019).  As health care costs grow out of control, consumers 
are becoming more impatient with policies that don’t show a demonstrable improvement.  
Price transparency is a start, which may pave the way towards competition, which has 
proven to lower costs in other markets (March, 2019) 
Conclusion 
 In order to arrive at the hypothesis that Healthcare Price Transparency Laws accomplish 
their goal of lowering the rate of increase in health care costs, several factors need to be considered.  
Does the average income of the population within each state influence the out-come?  Do age and 
chronic illnesses, and poverty play a role? A Multiple Linear Regression models including these 
factors as independent variables under the umbrella of the Healthy States index will help bring into 
focus what, if any, these questions have an impact on fleshing out the original question of whether 
or not Healthcare Price Transparency Laws do, in fact, accomplish their goal.   
 Whether or not these laws have a statistically significant impact on lowering the rate of 
growth in health care spending has yet to be determined.  But if they do, the implications can range 
from strengthening laws already on the books for those states that have adopted them, to creating 
a national framework of looking at specific mandates that are most – and least effective.  If the 








Chapter 4: Findings 
Descriptive Statistics 
 As shown in Table 4, the number of observations totaled 750 (15 years x 50 
states).  The minimum statistic shows that one of the states (Mississippi, 2013) had a negative 
9.5% rate of growth and the maximum statistic shows that one of the states (Alaska, 2001) 
had a 12% increase. The average rate of increase for all 50 states from 2000 to 2014 was 
4.85%.  There is a negative skew of .272 with the tail on the left of the mean, which means 
that the average rate of increase is less than the mean.  The states that show a rate of growth 
less than 4.85% are greater in number than those states with a rate of growth higher than 
4.85%. (figure 4).  The Standard Deviation of 2.1331 means that most of the data is clustered 
around the mean.  It also means that the average rate of growth is distance is 2.1331 from the 
mean (Statista, 2019).  Although there is a negative skew, for the most part, the data seems to 
have a normal distribution.  The kurtosis value of 2.299 means that the tail on either side is 
considered light and corresponds with the low Standard Deviation with the dispersion of data 








Table 6.  Descriptive statistics 
   
Descriptive 
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Fig.5 Dependent variable histogram 
 
   
 
 
Histograms for the I.V.’s I and II (years 1-15 and Health Care Price Transparency Laws) were 
not generated due to them not fitting the standard bell curve format.  The Min/Max for years 2000-2014 
is 2000/2014.  The mean is 2007 and the Std. Deviation is 4.323  
The histogram (figure 5) for the independent variable Values shows that the data is negatively 
skewed with the standard deviation five times that of the mean. This means that the data is more widely 
distributed with a greater distance from the mean than the dependent variable histogram in figure 3.   It 
also shows negative kurtosis with a light tail and flatter peak. 
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 The R Square (correlation coefficient) helps us determine the ‘goodness of fit’ in 
the regression model.  A value close to 1 tells us that the variability of dependent variable can be 
explained by the independent variables (Hamilton, Ghert, Simpson, 2015). In the Model 
Summary below, 44% of the variability of the dependent variable (increased rate of growth) is 
explained by the independent variables of years, values, and HCPTL laws and 56% of the 


















1 .667a 0.445 0.443 1.5916 




Table 8 shows the beta coefficients and p values (significance) for the model.  For an 
independent variable to be statistically significant, the p value must be lower than 0.050.  The 
beta coefficient measures the strength of the effect, either positive or negative, the independent 
variable has on the dependent variable. 
 








    95.0% Confidence 






 Upper       
Bound 
1 (Constant) 663.836 27.065 
 
24.527 0.000 610.703 716.968 
Law 0.089 0.124 0.020 0.717 0.474 -0.154 0.332 
Value 0.195 0.104 0.051 1.883 0.060 -0.008 0.399 
Year -0.328 0.013 -0.666 -24.347 0.000 -0.355 -0.302 






In table 9, the only independent variable that is statistically significant is the one that 
contains the years 2000-2014.  There is a negative beta coefficient of -0.666 which means that 
for every unit of increase, the average rate of growth decreases by 6.6%.  This corresponds with 
the raw data as shown in table 10 below: 
                              
Table 9. Average rate of increase in health care costs from 2000-2014 
Ave rate 
of 
Increase Years State 
10 2000 Alaska 
12 2001 Alaska 
9 2002 Alaska 
7 2003 Alaska 
6 2004 Alaska 
10 2005 Alaska 
4 2006 Alaska 
6 2007 Alaska 
6 2008 Alaska 
3 2009 Alaska 
4 2010 Alaska 
5 2011 Alaska 
5 2012 Alaska 
3 2013 Alaska 
6 2014 Alaska 
   
 
 
The independent variable for values is close to being statistically significant at 0.060.  
The composite z-scores that help make up the Healthy State Rankings show that for every unit of 
increase the average rate goes up goes up by 5% with the beta coefficient at 0.051.  The variable 
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that shows the least correlation is the primary variable HCPTL at .474 with the beta coefficient 
of 0.020 
 In order to give transparency, the benefit of the doubt, additional regressions were run 
where the primary independent variable coding was changed from dichotomous to a spectrum 
based on the layers of transparency.  The common criteria among the states chosen was the same 
as in the original model.  States had to require a database where consumers could access price 
information.  The spectrum is as follows: Arizona-2, Arkinsas-1, California-13, Colorado-3, 
Florida-8, Illinois-5, Kentucky-1, Minnesota-4, Nevada-2, New Hampshire-3, North Carolina-4, 
Ohio-7, Pennsylvania-2, Rhode Island-2, South Dakota-4, Texas-4, and Vermont-4.  The rest of 
the states were coded 0.   
Alternate model summary 
 The alternate model summary in table 10 below for the alternate regression closely 
resembles the first model (See Table 7)  
 





















The adjusted R Square is approximately the same which means that 46% of the variation in the 
dependent variable is explained by the independent variables. While this is true of the Model 
Summary, the coefficients (Table 11 below) for the primary independent variable are far 
different.  The beta coefficient turned from positive to a negative beta coefficient which means 
that for every unit of increase the rate of growth goes down 1%.  While this is an improvement in 
the rate of growth, the model still shows that there is no statistical significance between the 
primary independent variable and the independent variable. 
 
 





Coefficients t Sig. 
  Beta     
1 (Constant) 663.526 26.989   24.585 0.000 
  Year -0.328 0.013 -0.665 -24.406 0.000 
  Law -0.003 0.023 -0.004 -0.150 0.881 












 Overall, the model used in this research had poor outcomes showing no statistical 
relationship from the primary independent variable.  The I.V. with the greatest relationship was 
‘Values’ with a p value of 0.00.  The inconclusive findings, as it relates to the primary 
independent variable – and focus of this study - corresponds to the conclusions of those who 
have tried to determine the effectiveness of price transparency in lowering health care costs 
(Mehrotra, et al, 2018), (Berstein, 2018), (Castelluci, Livingston, 2019).  Researching the effects 
of health care price transparency is a relatively new and a great deal is centered on consumer 
access and lack of transparency, and quality improvement.  According to Dr. Scott Gazelle, 
Institute for Technology Assessment at Massachusetts General Hospital, states that “More 
generally, to optimize the benefits of healthcare spending, resources must be allocated based on 
the relative cost-effectiveness of specific healthcare services. In a very real and meaningful 
sense, therefore, “cost-effectiveness” defines value, and cost-effectiveness analysis is an 
essential component of any strategy that seeks to incorporate value transparency into healthcare 
reform.”  (The Health Care Imperative, 2010). 
There could be many reasons as to why the only statistically significant variable of 
‘years’ is the only factor in the model that shows a decrease in costs.  More people may have 
decided that taking steps to improve their health became a priority.  Perhaps competition, 
although not measurable, could be the reason the rate of growth decreased. There are too many 





Chapter 5: Conclusion 
Forms of Transparency 
 This chapter focuses on the several ways transparency may impact the health care market 
in ways that are not reflected in lowering costs.  There are many positive reasons why 
transparency is important. The reasons listed below are only a small fraction of the many ways’ 
transparency promotes business relationships that benefit consumers.  Although the health care 
market is unique in that it doesn’t follow the fluctuating trend of supply and demand (demand 
will always be high) there are still some lessons from the basic business model that can benefit 
the health care market. The primary benefits are listed bel0w. 
Transparency may improve quality standards 
  One of the ways transparency may affect health care can be found by quality indicators.  
How high, or low, are hospitals ranked in comparison to other hospitals in the same rural or 
urban setting?  With rating companies on the internet increasing consumer accessibility, this 
component can impact consumer choice, which in turn, can spur hospital administrators to take 
these rankings seriously by incorporating higher standards of care/patient services into their 
mission statements and quantify them internally by setting a required standard of care their 
employees must meet. 
Transparency may promote competition 
Indirectly, transparency may promote competition among hospitals.  Now that every 
hospital is required to make public their actual costs as outlined by the executive order signed by 
President Trump in 2019, this new law may have decision-makers take a closer look at their own 




Transparency may prevent over-charging 
Transparency in many markets and institutions are increasing.  We see this happening in 
school districts, the resort industry, and car sales and how property tax bills are broken down in 
order to give taxpayers a better understanding of what they are being charged.  In terms of the 
State of Nevada, the legislature voted to pass NRS 361.485 to ensure that property tax bills are to 
be formatted in such a way that the home-owner can easily tell if they were over-charged for 
reasons such as an incorrect tax percentage was used to calculate their tax rate.  This affords the 
taxpayer the ability to challenge the total being charged (Nevada Department of Taxation, 2012).  
The same may hold true for patients because they will have notice written in advance of a 
procedure to compare with their actual bill.  This will only hold true if more work is done on 
cleaning up issues that stymie coming close to actual costs such as using generalities when 
estimated costs include negotiated discounts, complications, and other means by which hospitals 
calculate costs. 
Conclusion 
Finding solutions to combat spiraling health care costs is not an easy task.  For decades, 
the federal government has made several attempts to do so by analyzing the approaches other 
countries have utilized to control costs while also creating greater access for its citizens.   While 
the Affordable Care Act has been successful in enlarging the number of people who now have 
health care coverage, depending on which expert you speak with, the results are mixed.  
According to a Congressional Budget Office report, The Affordable Care Act has lowered the 
costs of health care by a combination of reducing Medicare payments to hospitals (who recoup 
their costs by seeing more insured patients), fees on pharmaceutical companies, and higher 
Medicare taxes on those who earn $200,000.00 individually or $250,000.00 as a couple and 
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employer tax penalties, of $2,000.00 for each employee not covered by insurance, for those 
companies with more than 50 employees (Amadeo, 2018).  However, these savings were not 
created in a vacuum.  Someone, usually the consumer, bears these costs directly as the additional 
costs from higher fees placed on the drug companies are passed along to the insurance 
companies or patients themselves.  Indirectly, the tax burden placed on individuals/couples in 
higher brackets, in order to subsidize health care coverage for those who cannot afford it,  
reduces disposable income that would otherwise be spent on goods or services that generate 
revenue and put back money into the economy.   
Although this research did not find a significant relationship between health care data 
transparency laws and lowering of health care costs, there are other metrics that point to positive 
effects of requiring transparency.  Included in this research are tables showing how each state 
fairs against the national average broken down by states that require transparency (Tables 8-11) 
and those that do not (Tables 12-15).  
For far too long, health care costs have been shielded from the light of day due to lack of 
oversight in the health care industry.  Hospital billing is complex and there doesn’t seem to be 
any rhyme or reason to it.  For example, there are negotiated discounts for some insurance 
providers who pay a different rate for the same procedure at the same hospital for one patient and 
a different rate for another patient with the same coverage.  By providing upfront cost estimates 
for tests, such as imaging scans, can help patients weigh whether an expensive test is needed 
given their current circumstance.  Transparency can also be a catalyst in generating greater 
transparency, so while most experts are uncertain that transparency alone lowers healthcare 
costs, it is still viewed as a useful endeavor (Castellucci, Livingston, 2019).  By mandating that 
hospitals disclose costs, consumers are better equipped to make informed health care decisions, 
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but there are limitations to the choices they can make.  The same authors note that it is difficult 
to estimate an approximate cost of any given procedure because there are unknown risks of 
complications that may occur depending on the complexity of the operation.  There is also the 
issue of a consumer being blocked from using the services of a given hospital/Ambulatory 
Surgery Center (ASC) either due to their physician not having privileges to carry out procedures, 
as well as their insurance company choosing to, for whatever reason, forego a contract with that 
hospital/ASC.  While information is empowering, it can also be a source of frustration when the 
consumer is locked out of being able to choose the facility with the lowest cost for reasons that 
are beyond their control. 
This chapter took a deeper look at the raw data of those states that enacted health care 
data transparency laws and those that have not.  Included in this comparison was how they fared 
against the national average.  For the most part, the results aligned with the results included in 
chapter 4.  It also looked at the positive and potential drawbacks that transparency provides.  
Given the right circumstances, transparency has the potential to create competition, become an 
impetus for further discussions about possible solutions towards simplifying Chargemasters, and 
educating consumers.  Chapter six will focus on limitations that are currently present in health 








Summary of Health Care Data Transparency Laws 
Out of the 28 states that have enacted Health Care Data Transparency laws, 15 of them 
created a single layer of transparency that either mandates health care facilities submit data to a 
state entity (Delaware, Indiana, Maine, Missouri, Rhode Island, Pennsylvania and Utah) or 
require hospitals to provide approximate costs for procedures up front (Arkansas, Kentucky, 
Minnesota, Nebraska, Nevada, South Dakota, Texas, and Washington State). 
The following nine state legislatures have passed transparency laws that require health 
care facilities provide both data to a state entity for auditing purposes and price transparency: 
Arizona, Colorado, Florida, Illinois, North Carolina, Ohio, Oregon, Virginia, and Wisconsin. 
California, Florida, and Vermont must disclose pharmaceutical pricing along with price 
transparency requirements.  New Hampshire also offers information on insurance price coverage 
and costs for the uninsured.   
Up until January of 2019, California was the only state to require public access to a state-
wide Charge Master.  California is unique in that it has the most extensive layers of transparency 
in the nation.  It not only requires that hospitals licensed in this state provide patients cost 
estimates, it “requires health insurance carriers to provide coverage for prescription drugs to 
‘provide notice in the evidence of coverage and disclosure forms to enrollees regarding whether 
the plan uses a formulary” (NCSL, 2017).  California also requires insurance companies to post 
mental health benefits and all insurance carriers provide direct access to consumers regarding 





Chapter 6: Discussion 
 
This chapter covers the limitations of health care price transparency laws, as well as 
recommendations for future research. 
Limitations 
Lack of Standardized Data 
 One glaring limitation of this research model is that the data used for the Primary 
Independent Variable is not standardized.  As noted in chapter 5, in the summary of health care 
transparency laws, the states that passed these laws did not use the same requirements.  Some 
states only required that health care facilities submit billing or utilization data.  Other states were 
more layers of transparency by including insurance and prescription drug costs be made 
available to consumers.  Because this research focused on consumer access to information on 
costs, 11 of the 28 states had to be excluded from this study.  The smaller sample size may have 
affected the outcome of this research. 
Emergent vs. Non-Emergent 
Another limitation that may impact how to measure the relationship between price 
transparency costs is the fact that transparency is of little to no use in an emergency situation.  
The Annals of Emergency Medicine notes that, “It's difficult to shop for emergency care, of 
course, because nobody plans to have a health crisis.” (Greene, 2014). Few people will care what 
a test or drug costs when faced with a life-or-death situation.  The Health Care Utilization Project 
estimates that between 2006 and 2014, over 50% of hospital admissions were the result of 
Emergency Department visits (Moore, Stocks, Owens, 2017).  This means that less than 50% of 
53 
 
health care price transparency is useful. Because of this, it is possible that the results of the 
regression were skewed because not all of the data could be considered useful. 
Lack of exposure 
For now, only a limited number of consumers (mostly uninsured and those who pay cash) 
access hospital chargemasters (Bai, Patel, Makary et al, 2019).  According to an article in the 
Journal of the American Medical Association (JAMA), in a study conducted on 148,655 patients, 
only 10% searched for price information (Sinaiko, 2019).  Because the sample size is relatively 
small, this may be a factor in skewing results of any quantitative model.  Although this is the 
case now, when insurance companies increasingly move towards only offering higher deductible 
plans, more and more consumers are going to need to access chargemaster and other health care 
price data to compare pricing and to leverage negotiating power. Most web portals count ‘hits’ to 
their sites, but it is impossible to know whether or not it is several people accessing the site once, 
or one person accessing the site several times.  It is also impossible to know whether the average 
consumer is accessing this data or if researchers are using the portals.  One way to correct this 
would be to conduct surveys on consumers’ perceptions on usability of the information in its 
current format. In order for this to happen, though, a greater percentage of the population needs 
to know that the information is available to access.    Creating public awareness through 
private/public collaboration via social media and other outlets could be used to increase 
consumer awareness.  
At this time, there does not appear to be a lot of advertising in those states that have 
passed health care price transparency laws, although the new executive order signed in 2019 
mandating that all hospitals, drug, and insurance companies post actual costs has received a lot 
of press.  This is a promising outcome.  However, awareness does not necessarily equate to 
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greater use if there is not a change in how this information is disseminated. Until there is 
pressure placed on hospitals to present charges that consumers can understand with more 
accuracy, it is hard to quantify whether transparency lowers costs.  
Future Research 
 Rectifying the following issues may help create a path that benefits future research in the 
area of health care price transparency.  Areas where correction is needed most is in the areas of 
information asymmetry, principle agent problem, and accountability. 
Information Asymmetry 
There are quite a few limitations that inhibit research in this area if transparency’s stated 
goal is to lower costs through educating the public.  Primary among them is information 
asymmetry.  Information asymmetry theory posits that an imbalance exists between two entities, 
such as a patient/doctor in which the entity that has more knowledge can manipulate information 
to their own advantage (Miller, 2019). This is also true of how hospitals post charges.  The 
example in chapter 2 highlights how confusing charge coding is.  Not only is there no 
consistency between how hospitals report charges on their Chargemasters (Bekker, 2019) but the 
charges they do post reflect very little on the actual costs.   
In January of 2019, CMS (Centers for Medicare and Medicaid Services) began requiring 
hospitals post charges so that consumers can access the information (Chmura, Jackson, 2019) 
(Deady, 2019).  This new law may go a long way towards providing clean data over time for 
future research.  According to the Kaiser Family Foundation, the new law only requires that 
hospitals post the charges, not how understandable the charges are (KHN, 2019).   In other 
words, the law does little to reduce information asymmetry.  Perhaps this new law will provide 
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uniformity in terms of requiring all hospitals in every state to comply, which in turn, will remove 
some of the obstacles to this type of research.  In fact, according to an article published by the 
Kaiser Family Foundation, the latest push by President Trump for more transparency, “It’s also a 
potentially crushing amount of data for a consumer to consider. However, the administration said 
it hopes the data will also spur researchers, employers or entrepreneurs to find additional ways of 
making the data accessible and useful.”  In order to help consumers understand pricing 
information, the new law also acknowledges that, “In a nod to how hard it might be for a 
consumer to add up items from such an a la carte list of prices, the rule also requires each 
hospital to include a list of 300 “shoppable” services, described in plain language, with all the 
ancillary costs included. So, in effect, a patient could look up the total cost of a knee 
replacement, hernia repair or other treatment.”  (Applebee, 2019). 
Principle Agent Problem 
 According to the Intelligent Economist (2019), Principle Agent Problem can be 
described, in the health care, as the practitioner (agent) making decisions on behalf of the 
principle (patient).  In this way, Principle Agent Problem is closely tied to information 
asymmetry in that the less a patient knows about medicine, the more likely they are to defer to 
their physician to make health care choices for them.  One of the consequences of Principle 
Agent Problem is the abuse of power.  In the field of health care, there is no to know whether or 
not a surgeon is pushing for a particular medical device, such as a very expensive artificial hip, 
because it is the best option for a particular patient, or is the surgeon financially tied to the 
manufacturer.   
 In the right circumstances, transparency is supposed to correct the tendency towards 
abuse of power by equipping consumers to ask questions related to costs.  But, information 
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asymmetry precludes this from happening.  If policymakers are serious about providing the 
public with the inherent benefits of transparency, mandating that hospitals post charges in a way 
that is easily understood will go a long way towards achieving this goal. 
Muddying the waters even more is the fact that hospitals are notorious for over-charging.  
Even Medicare isn’t shielded by hospitals attempts to overcharge.  In 2018, Banner Health had to 
pay $18M because they were caught defrauding Medicare (LaPoint, 2018). 
Accountability 
  
Future research on this topic may depend on a couple of changes to the way hospitals 
report their charges. Transparency without accountability is meaningless.  It is not enough to 
allow hospitals to follow the letter of the law without also mandating that they follow the spirit 
of the price transparency laws.  Competition cannot be created, nor can consumers educate 
themselves about the costs of health care as long as the chargemasters in their current form are 
allowed to continue.  But, more importantly – if we are serious about price transparency’s ability 
to lower cost – hospitals must be forced to justify their charges.  The most vulnerable amongst us 
are the uninsured, and even the most ambitious laws, like the Affordable Care Act, could not 
cover everyone.  Yet hospital billing frequently overcharges these patients, and if the uninsured 
patients don’t pay for treatment they receive, hospitals sometimes cost shift by charging the 
insured a higher price (Norman, 2019). 
Conclusion 
For far too long, hospitals have been counting on the public’s ignorance with regards to 
how much they charge for a particular procedure.  There are countless stories of uninsured 
patients being over-charged for the same procedures than patients covered by health insurance 
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(Mundy, 2019).  Huffington Post notes that a study conducted by the Journal of American 
Medicine (JAMA) states that Emergency Room visits can cost uninsured patients up to four 
times as much as those who are covered by Medicare (Emery, 2017). Health care price 
transparency is of no value because of the internecine workings of how procedures are billed 
based on the type of coverage the patient has. 
In some ways, hospitals should operate like any other market.  Transparent, easily 
understood prices should be easily accessible in order to create competition.   Much like going to 
a grocery store where costs are clearly marked.  But, in many ways, health care is unlike any 
market in existence.  Demand will always be high, and unlike deciding whether or not to have 
our car repaired or take a different mode of transportation, it is neither feasible, nor 
recommended that we hold off going to an Emergency Room when experiencing severe chest 
pains or other emergent trauma.  Hospitals know this and leverage information asymmetry in 
times of the crisis to add to their bottom line.  For this reason, President Trump stated that, “it’s 
time for Congress to pass a law that stops hospitals and insurance companies from hitting 
patients with surprise medical bills” (Mazzolini, 2019). 
 It is understandable that hospitals and physicians must recoup costs.  Physicians have 
student debt and Malpractice Insurance.  Hospitals must pay for overhead, updated machinery.  
Pharmaceutical companies have to charge high prices for life-saving drugs to incentivize future 
research and development.  While all of this is true, the veil that shrouds so much of the cost’s 
hospitals charge needs to be lifted if the health care price transparency laws are ever going to 
have any chance of being effective in lowering health care costs.  Lifting the veil through 
transparency laws may not lower costs, but its potential benefits, if nothing more than sparking 
conversation on this topic, are very real. 
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Appendix A: Theoretical Framework 
  While most of the research carried out in this dissertation focused on results rather 
than policy creation, the theoretical framework is core to understanding how these policies are 
created.  Understanding the framework helps pinpoint the context as to why certain mandates are 
passed at the federal or state level.   
The theoretical policy framework used for this research originated with Francis Stokes 
Berry and William D. Berry’s Innovation and Diffusion Models in Policy Research.  This model 
distinguishes itself from other policy frameworks because it focuses on policy at the individual 
state level (Sabartier, 2007).  Berry and Berry argue that while much policy at the federal level is 
incremental, states are sometimes forced to become creative when solutions at the federal level 
don’t exist, “…Ultimately every government program can be traced back to some non-incremental 
innovation” (Sabatier, 223). The premise for this model is that states tend to copy innovations 
created by neighboring states depending on how successful the policy outcome is for the state that 
initiated the policy.  Other factors can also contribute towards one state emulating another state’s 
policy such as ideological compatibility, or networking are some of the reasons why adoption of a 
policy takes place.  These are included below. 
 There are six diffusion models: National Interaction Model, Regional Diffusion Model, 
Leader-Laggard Models, Isomorphism Models, Vertical Influence Models, Internal Determinants 






National Interaction Model 
 This model focuses on interactions at the national level where state representatives 
(legislatures/executives) network with those who hold the same positions in other states and share 
program data via these interactions.  The probability that other states will adopt similar policies is 
proportional to the number “…interactions its officials have had with officials of already-adopting 
states” through social systems such as National Governor’s Association or National Conference of 
State Legislatures (Sabatier, 226) 
 The primary assumption is that at any time period, all states that have not yet emulated the 
policy in question are capable of adopting said policy at any given time.  While this may be true 
at the national level, Berry and Berry underscore the fact that some state networks have a greater 
interaction with peers based on professional commonality. (Sabarier, 228). For purposes of this 
research, it is hard to determine if this model has any impact because the scope of determining 
influence from one legislative body upon another.   
The Regional Diffusion Model 
 Unlike the National Interaction Model, this model looks at policy adoption based on 
whether or not the policy initiative was created by a state that shares the same border.  Another 
term for this model is neighbor models (Sabatier, 229).  This model is not limited to just bordering 
states.  Berry & Berry argue that this model can encompass fixed regions.  Much like the neighbor’s 
model, it is believed that competition exists amongst those states in close proximity will adopt a 
given policy.  This would hold true in cases where states relatively close to each other compete for 
revenue through either a lottery system or by-passing legislation that gives monetary incentives to 
businesses, through lower taxation, in order to attract companies to move their base of operations 
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within their borders.  While both the fixed-regional model and neighbor model seem quite similar, 
there are distinctions.  The fixed-regional model’s underlying assumption is that states that happen 
to share a border with a state in another region will not necessarily share the same sphere of 
influence.  On the other hand, the neighbor model hypothesizes that states that do not share a 
border will not exert influence over those states within the same region (Sabatier, 229).   
A preliminary look shows that there are some geographical clusters of states that have adopted 
healthcare data transparency laws – especially in the West Coast. Note that every state is bordered 
by at least one state that has adopted HCDTL’s. 
Leader-Laggard Models 
 This model assumes that leaders, rather than competition, are the primary influence in 
terms of policy adoption. An apropos example of this can be found in a headline from the New 
York Times: The Nation: Golden Rules; As California Goes, So Goes the Nation.  There is a grain 
of truth to this maxim as California sees itself, as does the rest of the country, as trend-setters in 
such areas as environmental policy, stem cell research, or immigration policy.  Ironically, it is 
gridlock at the federal level that gives rise to such innovations at the state level (McNamara, 2006).  
One of the weaknesses of this model is that it is hard to predict which states will emerge as 
pioneers, or “…the states (or even types of states) that are expected to follow” (Sabatier, 230).  As 
one of the hallmarks of any scientific theory is replication, (National Academy Press, 2002), the 
Leader-Laggard model falls short – with one exception.  Collier and Messick, (Sebatier, 230) argue 
that a hierarchical correlation exists between policy innovation and diffusion where economically 
developed countries are more likely to initiate policy while those countries/leaders less 
economically developed tend to follow (Sabatier, 230).  In this way, the hierarchical model 
resembles Maslov’s Hierarchy of Needs on a grander scale, in that the more a society is able to 
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take care of immediate/primitive needs such as maintaining security and economic stability, the 
greater the chance that government has in being able to provide safety nets like Social Security 
(Burton, 2012). 
Isomorphism Models 
 The predicate for the Isomorphism Model is not so much based on geographical proximity 
but ideological alignment.  While it is true that other factors may play a part in whether or not a 
state adopts similar policy, such as population, and natural resources, these considerations take a 
back seat to political ideology (Sabatier, 230).  The level of complexity, in terms of the separate 
types of transparency required by each state differs greatly.  Of the 24 states that require 
transparency, six of the states require five or more separate mandates.  These states are as follows: 
California (14), Illinois (5), Ohio (7), Oregon (6), Virginia (5), and Wisconsin (10). An argument 
can be made that because all of these states are considered Blue states, that there is at least some 
form of Isomorphism taking place – even if at a modest level.                                                          
  Vertical Influence Models 
 In some ways the Vertical Influence Model mirrors the Leader-Laggard model except that 
instead of a particular state’s innovation diffusing across other states, the federal government 
serves as the leader of policy innovation.  Where this model differs from the Leader-Laggard model 
is the fact that the federal government has the power of wielding the carrot and the stick via the 
use of offering, or withholding, financial incentives called Grant-in-Aid or block grants.  Although 
individual states are in charge of governing education and law enforcement, how these programs 
are paid for comes, in large part, from these federal grants (Sabatier, 231).  In current events, we 
see this play out in our immigration policy.  Our current president has threatened to revoke funding 
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from states that do not conform to federal immigration policy such as sanctuary cities. In terms of 
Health Care Data Transparency Laws, there does not appear to be any vertical influence taking 
place as all the mandates originate at the state level. 
Conclusion 
 In order to arrive at the hypothesis that Healthcare Data Transparency Laws accomplish 
their goal of lowering health care costs, several factors need to be considered.  Does political 
ideology play a part in raising/lowering healthcare costs?  Does the average age and income of the 
population within each state influence the out-come?  A multi-logit, and multiple liner regression, 
using these factors as independent variables will help bring into focus what, if any, of these 
questions have an impact on fleshing out the original question of whether or not Healthcare Data 
Transparency Laws do, in fact, accomplish their goal.  With regards to political ideology, a cursory 
glance does show that those states that lean conservative spend less in terms of actual and average 
dollars spent from 1991 to 2014.  This is true of those Red states that do and do not require 
HCDTL’s.  It is also true that those states that have enacted these laws, regardless of political 
ideology have lower healthcare costs per person, per capita than those states that do not have these 
laws on the books. It has also been determined that the adoption of these laws appear to follow at 
least two of Berry and Berry’s Innovation and Diffusion Models in Policy Research.  Namely, the 
Diffusion Model and the Isomorphism Model. 
 Whether or not these laws have a statistically significant impact on lowering health costs 
has yet to be determined.  But if they do, the implications can range from strengthening laws 
already on the books for those states that have adopted them, to creating a national frame-work of 
looking at specific mandates that are most – and least effective.  If the data shows there is no 
significant impact, how do we go back to the drawing board Individual states have the opportunity 
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to be innovative when it comes to setting forth mandates in the realm of lowering healthcare costs, 
and because this particular issue is so far-reaching, they have a moral obligation to do so.  But 
innovation without results does little for a population that bears the financial weight not only of 





















Appendix B: Raw Data Interpretation 
This section is included to visually interpret the data supplied by the Kaiser Family 
Foundation separate from the regression analysis.  The importance of this inclusion is to obtain 
information on possible trends in the data from each state compared to the national average. 
Raw Data Interpretation 
States with HCDTL (see table 12 - 15 below) as measured against the national average in 














































































































































































































































































































































































































































































































































































































































































































































































































































































































    































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































There are 17 states, out of 28 (60%) that paid out less than the national average either all 
15 years or a majority of them.  Of those 28 states, 17 of them passed laws that include public 
access to charge data (see page 30).   Just under 50% incurred charges that fell under the national 
average.  In looking at tables 10-13, there doesn’t appear to be a pattern with regards to the size 
of population or whether or not the state consists of primarily of rural or urban demographics.  It 
is interesting that California, a state with the highest population, by far, paid out less than the 
national average every year covered by this research. Of those states (22) that have not enacted 
health care data transparency laws, 17 states paid out less than the national average (77%).   As 
with those states that have price transparency laws on the books, there doesn’t appear to be any 
significant pattern as to why a majority of these states came under the national average (Tables 
16-19). 
 
Table 16. States without/HCDTL comparison against national average for costs from 
Alabama to Hawaii 2000-2014 
Year 
Nat’l 
Average Alabama Alaska Connecticut Georgia Hawaii 
2000 $4,118.00  $3,923.00  $4,566.00  $5,185.00  $3,606.00  $3,883.00  
2001 $4,428.00  $4,168.00  $5,169.00  $5,660.00  $3,806.00  $4,104.00  
2002 $4,755.00  $4, 1.00  $5,669.00  $5,944.00  $4,135.00  $4,407.00  
2003 $5,094.00  $4,994.00  $6,099.00  $6,226.00  $4,358.00  $4,750.00  
2004 $5,423.00  $5,252.00  $6,455.00  $6,739.00  $4,732.00  $5,018.00  
2005 $5,740.00  $5,545.00  $7,145.00  $6,997.00  $4,891.00  $5,389.00  
2006 $6,048.00  $5,755.00  $7,476.00  $7,391.00  $5,148.00  $5,555.00  
2007 $6,370.00  $5,928.00  $7,975.00  $7,793.00  $5,329.00  $6,098.00  
2008 $6,612.00  $6,067.00  $8,447.00  $8,219.00  $5,358.00  $6,382.00  
2009 $6,892.00  $6,325.00  $8,745.00  $8,740.00  $5,513.00  $6,542.00  
2010 $7,094.00  $6,421.00  $9,129.00  $8,863.00  $5,554.00  $6,496.00  
2011 $7,292.00  $6,541.00  $9,586.00  $8,950.00  $5,713.00  $6,527.00  
2012 $7,535.00  $6,821.00  $10,130.00  $9,300.00  $6,009.00  $6,803.00  
2013 $7,703.00  $6,996.00  $10,428.00  $9,517.00  $6,249.00  $6,955.00  
2014 $8,045.00  $7,281.00  $11,064.00  $9,859.00  $6,587.00  $7,299.00  
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Average Idaho Iowa Kansas Louisiana Maryland 
2000 $4,118.00  $3,394.00  $4,254.00  $4,247.00  $4,048.00  $4,239.00  
2001 $4,428.00  $3,651.00  $4,574.00  $4,556.00  $4,289.00  $4,604.00  
2002 $4,755.00  $4,008.00  $4,844.00  $4,853.00  $4,561.00  $4,985.00  
2003 $5,094.00  $4,252.00  $5,211.00  $5,149.00  $4,917.00  $5,380.00  
2004 $5,423.00  $4,492.00  $5,486.00  $5,489.00  $5,262.00  $5,737.00  
2005 $5,740.00  $4,799.00  $5,816.00  $5,786.00  $5,433.00  $6,064.00  
2006 $6,048.00  $5,057.00  $6,173.00  $6,040.00  $5,944.00  $6,530.00  
2007 $6,370.00  $5,309.00  $6,444.00  $6,352.00  $6,292.00  $6,907.00  
2008 $6,612.00  $5459..00 $6,691.00  $6,589.00  $6,618.00  $7,200.00  
2009 $6,892.00  $5,700.00  $6,946.00  $6,764.00  $6,958.00  $7,507.00  
2010 $7,094.00  $5,999.00  $7,177.00  $6,858.00  $7,227.00  $7,748.00  
2011 $7,292.00  $6,135.00  $7,416.00  $7,152.00  $7,161.00  $7,937.00  
2012 $7,535.00  $6,380.00  $7,648.00  $7,477.00  $7,303.00  $8,115.00  
2013 $7,703.00  $6,593.00  $7,806.00  $7,429.00  $7,487.00  $8,250.00  
2014 $8,045.00  $6,927.00  $8,200.00  $7,651.00  $7,815.00  $8,602.00  
       
 
       
Table 18. States without/HCDTL comparison against national average for costs from Michigan 
to New Mexico 2000-2014 
Year 
Nat’l  





2000 $4,118.00  $4,048.00  $3,728.00  $3,858.00  $4,741.00  $3,459.00  
2001 $4,428.00  $4,287.00  $4,087.00  $4,208.00  $4,990.00  $3,717.00  
2002 $4,755.00  $4,551.00  $4,415.00  $4,463.00  $5,397.00  $3,992.00  
2003 $5,094.00  $4,867.00  $4,708.00  $4,795.00  $5,679.00  $4,218.00  
2004 $5,423.00  $5,239.00  $5,091.00  $5,061.00  $6,006.00  $4,603.00  
2005 $5,740.00  $5,528.00  $5,387.00  $5,432.00  $6,434.00  $5,021.00  
2006 $6,048.00  $5,924.00  $5,792.00  $5,743.00  $6,727.00  $5,258.00  
2007 $6,370.00  $6,254.00  $6,175.00  $6,083.00  $7,098.00  $5,572.00  
2008 $6,612.00  $6,517.00  $6,422.00  $6,373.00  $7,319.00  $5,916.00  
2009 $6,892.00  $6,816.00  $6,615.00  $6,701.00  $7,727.00  $6,214.00  
2010 $7,094.00  $7,121.00  $6,642.00  $7,034.00  $7,778.00  $6,439.00  
2011 $7,292.00  $7,406.00  $6,833.00  $7,301.00  $7,947.00  $6,567.00  
2012 $7,535.00  $7,637.00  $7,369.00  $7,645.00  $8,269.00  $6,771.00  
2013 $7,703.00  $7,745.00  $7,362.00  $7,994.00  $8,444.00  $6,860.00  
2014 $8,045.00  $8,055.00  $7,362.00  $8,221.00  $8,859.00  $7,214.00  
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Table 19. States without/HCDTL comparison against national average for costs from New      











2000 $4,118.00  $5,086.00  $4,418.00  $3,765.00  $3,862.00  $4,104.00  $3,960.00  
2001 $4,428.00  $5,480.00  $4,836.00  $4,106.00  $4,238.00  $4,494.00  $4,270.00  
2002 $4,755.00  $5,884.00  $5,324.00  $4,360.00  $4,549.00  $4,702.00  $4,692.00  
2003 $5,094.00  $6,388.00  $5,524.00  $4,751.00  $4,834.00  $5,093.00  $4,990.00  
2004 $5,423.00  $6,783.00  $5,880.00  $4,971.00  $5,138.00  $5,523.00  $5,287.00  
2005 $5,740.00  $7,096.00  $6,205.00  $5,366.00  $5,403.00  $5,773.00  $5,683.00  
2006 $6,048.00  $7,518.00  $6,573.00  $5,680.00  $5,654.00  $5,950.00  $6,145.00  
2007 $6,370.00  $7,872.00  $7,010.00  $6,033.00  $5,889.00  $6,219.00  $6,545.00  
2008 $6,612.00  $8,098.00  $7,439.00  $6,366.00  $6,159.00  $6,305.00  $6,811.00  
2009 $6,892.00  $6542,00 $7,919.00  $6,504.00  $6,363.00  $6,449.00  $6,972.00  
2010 $7,094.00  $8,795.00  $8,325.00  $6,648.00  $6,554.00  $6,626.00  $7,301.00  
2011 $7,292.00  $9,016.00  $8,758.00  $6,921.00  $6,707.00  $6,742.00  $7,554.00  
2012 $7,535.00  $9,076.00  $8,977.00  $7,175.00  $6,853.00  $7,007.00  $7,833.00  
2013 $7,703.00  $9,351.00  $9,385.00  $7,293.00  $7,020.00  $7,106.00  $7,961.00  





 The raw data appears to support the regression analysis results listed in chapter 4 in that 
47% of those states that passed health care price transparency laws showed that less than half of 
their health care expenditures fell under the national average.  Conversely, of the 22 states that 
did not pass health care price transparency laws showed that 60% had health care expenditures 






Appendix C: Previous Models 
 
As time progresses, one of the aspects of any dissertation that evolves is the data set used in 
quantitative research.  As questions become more focused, variables change.  While this process 
is necessary, it is also important to document how the evolution manifests itself.  This section 
includes the original data set with the reasons for why the particular variables were chosen.  
Originally, the Dependent Variable used the total costs per state (as opposed to the current rate of 
growth).  The Primary Independent Variable remains dichotomous.  The other I.V.’s included the 
poverty rate for each state from 2000-2014, the percentage of elderly population per state for the 
same time-frame, as well as Urban vs. Rural.  Because of collinearity issues, it was decided that 
the best way to control for these variables was to use the Healthy States Rankings. The Red 
State/Blue State was initially included because it was thought to support the theoretical 
framework and attempted to capture the ideological paradigm often assigned to politicians where 
Blue State legislatures tend to view government as the primary problem solver, while Red State 
legislatures tend to view the free market as the source of lowering costs through competition.  
Eventually, this I.V. was abandoned.  Also note that originally, Florida and Nevada were 
excluded from the research because it was believed that including these states would create 
outliers in the data.  After further consultation with the committee, it was agreed upon that these 
two states should be included in the final data set. 
By assigning the costs that each state pays out per capita from 2000-2014 as the 
Dependent Variable (DV) and whether or not a state passed Healthcare Data Transparency Laws 
(0=no, 1=yes) as one of the Independent Variable (IV) we can control for other factors by 
including Independent Variables (II-VIII) that may also account for an increase in costs by 
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measuring whether or not an increase in poverty or elderly populations, as well as geographical 
and political ideological factors that may have an impact on raising, or lowering of healthcare 
costs at the state level.  The multiple linear regression will be run with the IV’s below: 
States (excluding Florida and Nevada) Northern states are coded 1/Southern states are 
 coded 0 
Health Care Data Transparency Laws (0/1) 
Costs per Medicare enrollee per state using data from 2000 to 2014. 
Average age 65 and older for each state (%).  
Average population living below poverty (%) 
Red State/Blue State (1/2) as determined by the presidential election cycle from 2000 to  
2012 
Urban/Rural (0/1) 
 Included in this methodology are tables that look at the states that do, and do not 
require transparency laws and the total amount paid by each state in per person, per capita 
costs for health care in 1991 and 2014. Although the regression model is limited to the 
years 2000-2014, it is important to capture descriptive statistics using the entire range of 
years as the span between the first state to enact HCDTL’s and the last state to do so is 
quite large. These tables also include the average costs, whether they are Red state/Blue 
state/ and the difference in costs by those states that fall within those attributes.   A map 
that shows the status of each state in terms of whether they are required to submit some 
form of data from  
billing records or upfront costs. A comparison of the political landscape in 2000 and 2012 
are included as these are the closest approximations to the 2000 and 2014 for presidential 
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elections.  Although this research focuses on decisions made by state political leaders, 
taking a snapshot of state legislatures – especially as they shift areas within the state due to 
gerrymandering would prove to be too chaotic.  This also holds true for those elected to 
Congress.  Attempting to use senatorial maps when election to this body are staggered is 
also difficult.  For this reason, using the presidential map anchors the data. 
According to the Raosoft Sample Size calculator where N=50, the sample size must be at 
least 45.   After removing both Florida and Nevada due to their higher than normal elderly 
population.  For the most part, health care costs are higher for the elderly due to chronic illnesses 
and the natural occurrences and frequency with which they are more likely to suffer (Gabel, 
Rice, 1986).   Both states will still be included in the discussion on healthcare data transparency 
laws.  The rest of the states will be included in this research for a sample size of 48 with a 95% 


















IV II IV III IV V IV VI Pop. 
IV VII 
Red/Blue IV VIII 
South 




in 2-Jan Rural/Urban 
        
 
poverty     
3932 0 0 5,381.00 13 13.3 1 1 
4168 0 0 5,842.00 13.1 15.5 1 1 
4511 0 0 6,223.00 13.1 14.5 1 1 
4994 0 0 6,606.00 13.1 15 1 1 
5252 0 0 7,180.00 13.1 16.9 1 1 
5545 0 0 7,545.00 13.2 16.7 1 1 
5755 0 0 8,717.00 13.2 14.3 1 1 
5928 0 0 9,041.00 13.3 14.5 1 1 
6097 0 0 9,465.00 13.5 14.3 1 1 
6325 0 0 9,714.00 13.6 16.6 1 1 
6421 0 0 9,818.00 13.8 17.2 1 1 
6541 0 0 9,976.00 14 15.4 1 1 
6821 0 0 10,022.00 14.5 16.2 1 1 
6996 0 0 10,075.00 14.9 16.7 1 1 
7281 0 0 10,267.00 15.4 17.8 1 1 
4566 1 0 5,167.00 5.7 7.6 1 1 
5169 1 0 5,382.00 5.9 8.5 1 1 
5669 1 0 5,704.00 6.1 8.8 1 1 
6099 1 0 6,039.00 6.2 9.6 1 1 
6455 1 0 7,401.00 6.4 9.1 1 1 
7145 1 0 7,197.00 6.6 10 1 1 
7476 1 0 7,706.00 6.8 8.9 1 1 
7975 1 0 7,724.00 7 7.6 1 1 
8447 1 0 8,092.00 7.3 8.2 1 1 
8745 1 0 8,629.00 7.6 11.7 1 1 
9129 1 0 8,556.00 7.8 12.5 1 1 
9586 1 0 8,880.00 8.1 11.7 1 1 
10130 1 0 8,833.00 8.5 10 1 1 
10428 1 0 9,143.00 9 10.9 1 1 
11064 1 0 9,288.00 9.4 11.9 1 1 
3226 0 1 4,756.00 13 11.7 2 0 
3438 0 1 5,191.00 13 14.6 1 0 
3779 0 1 5,591.00 12.9 13.5 1 0 
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4077 0 1 5,984.00 12.9 13.5 1 0 
4387 0 1 6,547.00 12.9 14.4 1 0 
4828 0 1 7,080.00 13 15.2 1 0 
5103 0 1 8,181.00 12.9 14.4 1 0 
5410 0 1 8,622.00 13 14.3 1 0 
5660 0 1 9,042.00 13.3 18 1 0 
5874 0 1 9,412.00 13.6 21.2 1 0 
6027 0 1 9,608.00 13.9 18.8 1 0 
6076 0 1 9,961.00 14.2 17.2 1 0 
6183 0 1 9,990.00 14.8 19 1 0 
6262 0 1 10,056.00 15.4 20.2 1 0 
6452 0 1 10,096.00 15.9 21.2 1 0 
3737 0 1 4,778.00 14 16.5 1 1 
4030 0 1 5,370.00 13.9 17.8 1 1 
 
 
The above data sets are compressed as the dependent and independent variables are comprised of 
15 years of data. A cursory look at the states that do not require healthcare data transparency 
from the table below highlights the following:  
The independent variables listed above were chosen because, with the exception of the 
median household income and age, they have either legislated that healthcare facilities make 
their costs known to both the body politic and/or the consumer, or there are significant 
characteristics that impact how policy actors go about creating legislation.  It is no secret that the 
more liberal the leaders of any given state are, the more likely he or she is to view solutions as 
emanating from governmental policy, while those who are elected in conservative states are 
more likely to see privatization as the solution to problems (Douthat, 2009).   
 While large cities tend to lean more towards voting for democrat candidates, this is not 
always the case.  In 2016, the Mesa, AZ and Virginia Beach voted for the Republican candidate 
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Donald Trump. (Finnigan, 2017) While some of the solid Blue States also voted Republicans into 
office as governor such as.  There is more than meets the eye when it comes to world views that 
differentiate the rural, rugged, farm hand and the urbanite.  Those who hail from the farmlands of 
Nebraska and coal mines of West Virginia tend to be more self-sufficient while at the same time 
place a greater importance on looking out for one another (DelReal, Clement, 2017).  
 Densely populated areas tend to be drawn towards unions or connections within 
government positions that offer greater retirement benefits packages.  This is a possible driver of 
healthcare costs because there exists the promise that while they may offer lower wages than their 
private industry counterparts, the idea of early retirement is a potent one (Burtless, 2011).  Since 
an individual tends to vote for a person who shares similar views, it is no coincidence that those 
who live in rural areas tend to vote Republican and a majority of those who live in urban areas 
vote for Democrats. This is also true of politicians (Blake, 2014). As this symbiotic relationship 
between a segment of the population and their political leaders cements itself, the priorities - and 
how their goals are accomplished starts to plays a part in how state legislatures see government’s 
role in solving problems – including the rising costs of healthcare, is defined by their world view. 



























The amount of dollars spent per capita from each state is included in this research because 
a possible correlation exists between the dependent variable of healthcare data transparency and 
lower costs as some believe that transparency lowers costs (Robert Wood Johnson Foundation, 
2016). (See breakdowns in state spending from tables 10-17 pgs. 42-46) 
In terms of how much is paid into healthcare costs by each state per capita can be explained 
by whether the state consists mostly of large cities (such as California) or rural areas such as Idaho, 
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or as explained earlier, in ‘retirement’ or Snow Bird states such as Nevada and Florida.  The data 
listed on the Kaiser Family Foundation site provides little explanation as to why each state arrives 
at these dollar amounts, do their population demographics consist of a larger proportion of people 
with chronic illnesses or those who live in poverty, which tend to be sicker than those who are 
financially well cared for? (Scott, 2016).  By adding the median age and household income per 
states as variables, this research might be able to glean some insight for the healthcare expenses 
being borne by each state.  
13 of the 24 states are Red states (see table 21 below) which lends itself to the theory that 
republican leadership tends to lean towards less oversight.  Another interesting fact is that, on 
average, Red states spent $663.00 less per person, per capita than their Blue state counterparts 
($73,898/13=$5,251.00-$65,058/11=$5,914.00.  Some of the difference can be attributed 












                    Table 21 States that do not have health care data transparency laws.  
State 1991 2014 Difference Red/Blue 
Alabama 2,535.00 7,281 4746 R 
Alaska 2,558 11,064 8506 R 
Connecticut 3315 9859 6544 B 
Georgia 2497 6587 4090 R 
Hawaii 2603 7299 4696 B 
Idaho 2124 6927 4803 R 
Iowa 2591 8200 5609 B 
Louisiana 2647 7815 5168 R 
Maryland 2786 8602 5816 B 
Massachusetts 3326 10559 7233 B 
Michigan 2663 8055 5392 B 
Minnesota 2698 8871 6173 B 
Mississippi 2174 7646 5472 R 
Montana 2355 8221 5866 R 
New Jersey 2956 8859 5903 B 
New Mexico 2240 7214 4974 B 
New York 3205 9778 6573 B 
North Dakota 2688 9851 7163 R 
Oklahoma 2366 7627 5261 R 
South Carolina 2262 7311 5049 R 
Tennessee 2556 7372 4816 R 
West Virginia 2597 9462 6865 R 
Wisconsin 2557 8702 6145 B 
Wyoming 2227 8320 6093 R 
Total Increase 
$138,956   Average Increase of $5,790.00 
 











Table 22.  States that have adopted health care data transparency laws 
     
State 1991 2014 Difference Red/Blue 
Arizona 2447 6452 4005 R 
Arkansas 2363 4708 2345 R 
California 2673 7549 4876 B 
Colorado 2498 6804 4306 B 
Delaware 2837 10254 7417 B 
Illinois 2729 8262 5533 B 
Indiana 2549 8300 5751 R 
Kansas 2613 7651 5038 R 
Kentucky 2385 8004 5619 R 
Maine 2548 9531 6983 B 
Missouri 2516 8107 5591 R 
Nebraska 2375 8412 6037 R 
New 
Hampshire 2457 9589 7132 B 
North 
Carolina 2263 7264 5001 R 
Ohio 2681 8712 6031 B 
Oregon 2308 8044 5736 B 
Pennsylvania 3019 9258 6239 B 
Rhode Island 2936 9551 6615 B 
South 
Dakota 2426 8933 6507 R 
Texas 2355 6998 4643 R 
Utah 1979 5982 4003 R 
Vermont 2340 10190 7850 B 
Virginia 2353 7556 5203 B 
Washington 2522 7912 5390 B 









For States that have adopted Healthcare Data Transparency Laws, the inverse is true (see 
table 22 above).  Red states have adopted Healthcare Data Transparency Laws as opposed to 13 
Blue states.  On average, these states have paid out less than $213.00 per person, per capita than 
those states that do not require at least some form of healthcare data ($5,790.00-$5,577.00) while 
Red states averaged $1.143.00 less than their Blue state counterparts ($6,101.00-$4,958.00)                                  
With regards to this study, as mentioned earlier, both Florida and Nevada have been excluded, so 
only the remaining 24 states will be included. As you can see from the map below (figure 8), 
transparency law policies have been enacted in 28 states.  
 





Appendix D: IRB Exclusion 
UNLV Social/Behavioral IRB - Administrative Review Notice of Excluded Activity 
DATE: August 13,2019 
TO: FROM: 
Nora Langendorf UNLV Social/Behavioral IRB 
PROTOCOL TITLE: [1473850-1] Lifting The Veil: Do Health Care Price Transparency Laws 
Actually Lower Costs? SUBMISSION TYPE: New Project 
ACTION: EXCLUDED - NOT HUIMAN SUBJECTS RESEARCH REVIEW DATE: August 
13,2019 REVIEW TYPE: Administrative Review 
Thank you for your submission of New Project materials for this protocol. This memorandum is 
notification that the protocol referenced above has been reviewed as indicated in Federal 
regulatory statutes 45CFR46. 
The UNLV Social/Behavioral IRB has determined this protocol does not meet the definition of 
human subjects research under the purview of the IRB according to federal regulations. lt is not 
in need of further review or approval by the lRB. 
We will retain a copy of this correspondence with our records. 
Any changes to the excluded activity may cause this protocol to require a different level of IRB 
review. Should any changes need to be made, please submit a Modification Form. 
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lf you have questions, please contact the Office of Research lntegrity - Human Subjects at 
IBE@Ulv.edu or call 702-895-2794. Please include your protocol title and lRBNet lD in all 
correspondence. 
Office of Research lntegrity - Human Sublects 4505 Maryland Parkway. Box 45'1047 . Las 
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